French AI-powered radiography diagnostics specialist Gleamer SAS has raises €27m in Series B round to expand its portfolio and accelerate its expansion.
https://european-biotechnology.com/wp-content/uploads/2024/04/Gleamer_Yemanja_c_JonathanMoyal-57-scaled.jpeg17072560Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-06-28 15:48:152024-07-09 16:32:21Gleamer raises €27m in Series B funding round